The lower house of the French parliament has approved a milestone requirement that pharmaceutical companies must disclose the amount of public funding that was used in the research and development of new medicines entering the national market, as well as allowing those contributions to be factored into negotiations over final drug pricing. After being initially […] Continue reading ->
Incarcerated people suffer from poorer health outcomes and limited access to health care, which can impact them and their communities even after release. However, prisoners’ health is not being monitored well, and there is a lack of evidence to inform policy making to improve the health of prison populations. These are the main findings of […] Continue reading ->
Italy’s former Undersecretary of State for Health, Armando Bartolazzi, discusses the implications of recent moves to replace the head of the Italian Medicines Agency (AIFA), based on political considerations of the a new Health Minister.   “Health is a Political Choice” said WHO Director-General Dr Tedros in his keynote session at the World Health Summit, […] Continue reading ->
In a move fraught with international political overtones, Italy’s new Minister of Health is moving to replace the Director General of the Italian Drug Agency (AIFA), Dr Luca Li Bassi, who was the key architect of the May World Health Assembly (WHA) resolution supporting greater price transparency in medicines markets, Health Policy Watch has learned. […] Continue reading ->
Bad Hofgastein, Austria – A call to action to make stronger individual and collective commitments for climate change and health marked the end of the European Health Forum (Gastein). The closing plenary session, titled “the global climate crisis: a public health emergency,” ended the varied program with discussions on two issues high on the political […] Continue reading ->
Bad Hofgastein, Austria – A stronger research agenda for cannabis is urgently required to guide European health policymakers through a bewildering maze of medical and recreational cannabis and cannabinoid products that are fast emerging on the European market, said researchers and policymakers at a panel session of the 2019 European Health Forum (Gastein), which concluded […] Continue reading ->
Bad Hofgastein, Austria – Whether its work or leisure, Europeans are moving more and more between different countries on the continent – but their health records generally lag far behind. And this can create big barriers to the treatment of chronic health conditions, not to mention effective diagnosis and treatment in emergencies, said members of […] Continue reading ->
Bad Hofgastein, Austria – Promoting an “economy of well-being” can drive European development agendas more sustainably, as well as making health systems more human-centered and responsive to client’s needs, said Finland’s Vice Minister of Social Affairs and Health in a keynote address Thursday at the European Health Forum (Gastein). The three-day conference, which began Wednesday, […] Continue reading ->